These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 19517245

  • 1. The contribution of serotonin 1A receptors to kappa opioid immunosuppression.
    Cheido MA, Idova GV.
    Neurosci Behav Physiol; 2009 Jul; 39(6):587-90. PubMed ID: 19517245
    [Abstract] [Full Text] [Related]

  • 2. [Impact of serotonin 1A receptors in the kappa-opioid immunosuppression].
    Cheĭdo MA, Idova GV.
    Ross Fiziol Zh Im I M Sechenova; 2008 Jul; 94(7):807-13. PubMed ID: 18767393
    [Abstract] [Full Text] [Related]

  • 3. Involvement of presynaptic 5-HT(1A) receptors in immunomodulation in conditions of psychoemotional tension.
    Idova GV, Davydova SM.
    Neurosci Behav Physiol; 2010 Jun; 40(5):495-9. PubMed ID: 20464516
    [Abstract] [Full Text] [Related]

  • 4. Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.
    Zhou X, Zhang R, Zhang S, Wu J, Sun X.
    J Neurosci; 2019 Feb 20; 39(8):1484-1504. PubMed ID: 30541912
    [Abstract] [Full Text] [Related]

  • 5. [Involvement of presynaptic 5-HT1A receptors in immunomodulation under conditions of psychoemotional state].
    Idova GV, Davydova SM.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2009 Feb 20; 59(2):206-12. PubMed ID: 19445389
    [Abstract] [Full Text] [Related]

  • 6. Significance of initial emotional state for neuroimmunomodulation in conditions of activation and blockade of 5-HT(1A) receptors.
    Idova GV, Davydova SM, Cheido MA, Zhukova EN, Devoino LV.
    Neurosci Behav Physiol; 2006 Sep 20; 36(7):703-7. PubMed ID: 16841149
    [Abstract] [Full Text] [Related]

  • 7. [Significance of initial emotional state for neuroimmunomodulation under conditions of activation or blockade of 5-HT1A receptors].
    Idova GV, Davydova SM, Cheĭdo MA, Zhukova EN, Devoĭno LV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2005 Sep 20; 55(4):567-72. PubMed ID: 16217972
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of 5-HT 1A receptors increases the seizure threshold for picrotoxin in mice.
    Pericić D, Lazić J, Jazvinsćak Jembrek M, Svob Strac D.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):105-10. PubMed ID: 16313900
    [Abstract] [Full Text] [Related]

  • 9. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
    Maraschin JC, Almeida CB, Rangel MP, Roncon CM, Sestile CC, Zangrossi H, Graeff FG, Audi EA.
    Behav Brain Res; 2017 Jun 01; 327():75-82. PubMed ID: 28347824
    [Abstract] [Full Text] [Related]

  • 10. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 11. [Presynaptic 5-HT1A receptors in immunomodulation].
    Davydova SM, Idova GV.
    Ross Fiziol Zh Im I M Sechenova; 2007 Oct 11; 93(10):1156-62. PubMed ID: 18074789
    [Abstract] [Full Text] [Related]

  • 12. Serotonin 5-HT(2) and 5-HT(1A)-like receptors differentially modulate aggressive behaviors in Drosophila melanogaster.
    Johnson O, Becnel J, Nichols CD.
    Neuroscience; 2009 Feb 18; 158(4):1292-300. PubMed ID: 19041376
    [Abstract] [Full Text] [Related]

  • 13. [The serotonin-dependent suppression of the immune response by kappa-opiate receptors].
    Chaĭdo MA, Idova GV, Devoĭno LV.
    Biull Eksp Biol Med; 1993 Sep 18; 116(9):291-2. PubMed ID: 7906960
    [Abstract] [Full Text] [Related]

  • 14. [Immune response under activation of pre- and postsynaptic serotonin 5-HT1A-receptors in mice with depressive-like behavior].
    Idova GV, Iur'ev DV, Kuznetsova SM.
    Ross Fiziol Zh Im I M Sechenova; 2010 Nov 18; 96(11):1097-102. PubMed ID: 21427969
    [Abstract] [Full Text] [Related]

  • 15. Activation of 5-hydroxytryptamine-1A receptors suppresses cardiovascular responses evoked from the paraventricular nucleus.
    Horiuchi J, Atik A, Iigaya K, McDowall LM, Killinger S, Dampney RA.
    Am J Physiol Regul Integr Comp Physiol; 2011 Oct 18; 301(4):R1088-97. PubMed ID: 21753144
    [Abstract] [Full Text] [Related]

  • 16. Activation of 5-HT(1A) receptors attenuates tachycardia induced by restraint stress in rats.
    Ngampramuan S, Baumert M, Beig MI, Kotchabhakdi N, Nalivaiko E.
    Am J Physiol Regul Integr Comp Physiol; 2008 Jan 18; 294(1):R132-41. PubMed ID: 17959705
    [Abstract] [Full Text] [Related]

  • 17. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.
    Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD.
    J Neurosci Res; 2009 May 15; 87(7):1645-58. PubMed ID: 19115412
    [Abstract] [Full Text] [Related]

  • 18. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar 15; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 19. Serotonergic control of ingestive and post-ingestive behaviors in pigeons (Columba livia): the role of 5-HT1A receptor-mediated central mechanisms.
    Hoeller AA, Dos Santos TS, Bruxel RR, Dallazen AR, do Amaral Silva HT, André ES, Marino-Neto J.
    Behav Brain Res; 2013 Jan 01; 236(1):118-130. PubMed ID: 22954717
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z, Rickard JF, Body S, Asgari K, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep 01; 181(2):381-91. PubMed ID: 15830225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.